Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAME-AL: EGCG for Cardiac AL Amyloidosis
NCT02015312Phase 2Completed
- Start
- Apr 2013
- Primary completion
- Oct 2017
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of epigallocatechin gallate in amyloid light chain amyloidosis. Started Apr 2013; status: completed.
02
Drugs
epigallocatechin gallate
03
Conditions
amyloid light chain amyloidosis
Beyond the preview
Go deeper on NCT02015312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02015312.